GENFIT to acquire Versantis to expand liver disease portfolio - Labiotech

Retrieved on: 2022-09-19 11:12:56

Tags for this article:

Click the tags to see associated articles and topics

GENFIT to acquire Versantis to expand liver disease portfolio - Labiotech. View article details on hiswai:

Excerpt

GENFIT is set to acquire Versantis, a Swiss biotechnology company focused on addressing the growing unmet medical needs in liver diseases.

Article found on: www.labiotech.eu